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and low anterior neck ( 50 Gy /25 #). The highest grade of 
mucositis assessed according to RTOG criteria and the time to 
development of that grade (in weeks since initiation) where 
noted in the data. The baseline characteristics of the 
patients utilized for the study are displayed in the table 
attached. All the statistical analysis was done using SPSS 
version 16.0.( table attached). 
Results: Of the analysed 122 patients , 44.4 % vs 59.3 % 
developed RTOG Grade 3 or4 mucositis after morning vs 
evening RT, respectively (p = 0.10) and the median time to 
development of severe mucositis was prolonged in the 
morning group (6 weeks vs 5 weeks). Morning RT was also 
associated with significantly lesser no of patients for whom 
treatment had to be interrupted due to severe mucositis 17.5 
% vs 40.7 % (p = 0.005). 58.2% of the patients who smoked (n 
=55) during RT , developed Grade 3 or 4 mucositis compared 
to 46.3 % who didn't smoke .(p = 0.396) Concurrent 
chemotherapy was associated with 65.2 % Grade 3 or 4 
mucositis compared to 35.7 % of patients who didn't receive 
concurrent chemotherapy. ( p= 0.001 ) 
Conclusions: Our analysis has shown a decrease in the 
development of severe mucositis when RT is delivered in the 
morning hours when compared to evening , though not 
statistically significant .The patients able to complete the RT 
course, without any interruptions , due to severe reactions 
were significantly higher in the morning session compared to 
evening . Advanced head and neck malignancies are still a 
difficult proposition to treat and hence limiting normal tissue 
toxicity is critical . The circadian rhythm of the cell cycle 
progression and its radiobiological potential need to be 
studied in detail. 
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Purpose/Objective: Several feature of zebrafish are making 
them amenable for investigation on therapeutic approaches 
such as ionizing radiation. The establishment of zebrafish 
model for comprehensive radiobiological research stands in 
the focus of our investigation, comparing the radiation effect 
curves of neutron and photon irradiation. Our final aim is to 
develop an appropriate vertebrate model in order to 
investigate the relative biological effectiveness of laser 
driven ionizing radiation. 
Materials and Methods: After careful dosimetry series of 
viable zebrafish embryos were exposed to a single fraction 
whole-body neutron-irradiation (1,25; 1,875; 2; 2,5 Gy) at 
the research reactor of the Technical University of Budapest 
and to conventional 6 MeV photon beam at 24 hour post-
fertilization (hpf). The survival and morphologic 
abnormalities (pericardial edema, spine curvature) of each 
embryo were assessed for each experiment at 24-hour 
intervals from the point of fertilization up to 168 hpf 
(defining the dose lethal for 50% (LD50)).  
Results: In the zebrafish embryo model LD50 at 20 Gy dose 
level was defined and the same lethality were found at 2 Gy 
dose from the reactor neutron beam resulting RBE of 10. 
Dose-dependent organ perturbations were detected on 
macroscopic (shortening of the body length, spine curvature, 
microcephaly, micro-ophthalmia, micrognathia, pericardial 
edema, and inhibition of yolk sac resorption) and microscopic 
(marked cellular changes in skin, cardiac, gastrointestinal 
system) with the same magnitude of dose difference. 
Conclusions: In our observations we found that zebrafish 
embryo model can be used for investigating the effects of 
different type of ionizing radiation and this system proved to 
be highly efficient vertebrate model for preclinical 
examinations. 
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Purpose/Objective: It has been reported that blood 
endothelial microparticles (EMP) contribute to blood 
coagulation activation, angiogenesis and inflammation as well 
are marker of endothelial cells (ECs) activation and/or 
apoptosis in various clinical settings. During radiotherapy 
(RT) or radiochemotherapy (RCT) of head and neck cancer 
(HNC) patients acute radiation reaction appears which is 
associated with ECs activation. However, information on EMP 
in HNC patients during RT/RCT is lacking. The aim of the 
study was to assess if EMP are a marker of ECs activation and 
damage as a result of ionizing radiation during the process of 
RT/RCT of HNC patients. 
Materials and Methods: Blood samples obtained from HNC 
patients undergoing radical RT/RCT (before, 1 day and 3 
months after its cessation) and from healthy control subjects 
were prospectively examined. Endothelial microparticles 
were measured by flow cytometry. The monoclonal 
antibodies purchased from Becton Dickinson, USA were used 
in the study: CD31 stained FITC, CD62E stained APC, PE-Cy5 
labeled anti-human CD42b, PE labeled anti-human CD142 and 
kappa isotype control: FITC labeled mouse IgG1, APC labeled 
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mouse IgG, PE-Cy5 labeled mouse IgG1 and PE labeled mouse 
IgG1. 
Results: Endothelial microparticles were significantly 
elevated in patients with HNC patients 
(CD31+/CD62E+/CD42b-: mean 1601±1479 EMP/µl; 
CD31+/CD142+/CD42b-: mean 121±135 EMP/µl) compared 
with control group (CD31+/CD62E+/CD42b-: mean 782±698 
EMP/µl; CD31+/CD142+/CD42b-: mean 688±647 EMP/µl). The 
concentration of EMP were not notably increased as result of 
RT/RCT (CD31+/CD62E+/CD42b-: mean 1629±769; 
EMP/µl;CD31+/CD142+/CD42b-: mean 1257±603 EMP/µl). 
There were no significant differences between EMP level 
before treatment, one day and 3 months after radiation 
cessation. Furthermore, there was no significant difference 
in plasma EMP level in plasma of the HNC patient undergoing 
RT alone, RT combined with chemotherapy, postoperative RT 
or postoperative RCT. 
Conclusions: The data suggest that the release of EMP is not 
a marker of ECs activation as a result of early response to 
ionizing radiation during RT/RCT in HNC patients. 
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Purpose/Objective: Prediction of the treatment response 
and overall outcome in patients is an important goal in 
radiation oncology. We aim to identify prognostic molecular 
features using gene expression profiling in gliomas. 
Materials and Methods: Data from [1] were used in this 
study. Total 152 samples including 100 glioblastomas, 21 
anaplastic astrocytomas, 19 diffuse astrocytomas and 12 
anaplastic oligodendrogliomas were selected for analysis and 
3456 genes expressed in gliomas, including 3012 unique 
sequences plus an additional 444 genes from a literature 
survey were identified. Different from using a selected 
training set in [1], the total 152 samples were included in our 
study. Progression–free survival (PFS) period was adopted as 
the clinical parameter for the treatment response. Pearson's 
linear correlation coefficients between the gene data and 
PFS record were computed for selecting the candidate genes 
for prognosis model. Hierarchical clustering was then 
computed based on the expression profile of selected genes. 
Cox proportional hazards regression was used to calculate the 
hazard ratios between different groups. 
Results: 47 genes are selected for our prognosis model and 
we have 29 genes in common with results in [1]. The 
unsupervised hierarchical clustering allows us to cluster the 
152 patients into three distinct groups based on their 
similarities measured over those selected 47 genes. The 
results of Kaplan-Meier analysis for all patients show PFS 
probabilities after 5 years are 70.2%, 0% and 25.7% for group 
1, 2 and 3 respectively. The cox proportional hazards 
regression analyses show hazard ratios 23.0, 8.8 and 0.6 for 
group 1&2, group 1&3 and group 2&3 respectively. The same 
method is also applied on the non-glioblastoma patients, 
which are able to be clustered into two groups with PFS 
probabilities after 5 years 76.0% and 0% for group 1 and 2 
respectively. The hazard ratio is calculated to be 25.5. 
 
 
 
Conclusions: In our analyses, the selected profiling results 
are useful in constructing a classification scheme and the 
unsupervised clustering method also succeeds in dividing the 
samples into good and poor prognosis groups. Compared with 
the results in [1], the good prognosis group in our result has 
higher PFS probabilities after 5 years and the unsupervised 
method is direct and easy to prevent the possible bias in the 
selection of training set in the supervised method. 
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